99mTc-FAPI-46 Scintigraphy in Genital Tract Carcinosarcoma
A 47-year-old woman presenting with abdominal pain and constipation was diagnosed with high-grade mucinous adenocarcinoma of the genital tract after undergoing extensive surgery. Six months after adjuvant chemotherapy, she developed recurrent symptoms and a large pelvic mass, leading to cytoreductive surgery, which histopathologic evaluation revealed carcinosarcoma. Postsurgery, 99mTc-FAPI-46 scintigraphy indicated heterogeneous uptake in the tumoral masses and diffuse uptake in peritoneal carcinomatosis, which was not detected on contrast-enhanced CT (CeCT) scan. This case demonstrates the superior diagnostic performance of FAPI-targeted imaging over CeCT in assessing tumor extent in genital tract carcinosarcoma and suggests 177Lu-FAPI as a potential therapeutic approach.
Authors
- Kamran Aryana (ORCID: https://orcid.org/0000-0003-2403-8903)
- Somaye Barashki (ORCID: https://orcid.org/0000-0002-3507-2077)
- Ehsan Soltani (ORCID: https://orcid.org/0000-0002-2158-7221)
- Nasrin Raeisi (ORCID: https://orcid.org/0009-0005-2087-2169)
- Amin Saber Tanha (ORCID: https://orcid.org/0009-0008-0290-0412)
Institutions
- Mashhad University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1097/rlu.0000000000006027
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00